(Q35123248)

6 August 2017

Chemoprevention of prostate cancer. Focus on key opportunities and clinical trials (English)

1 reference

6 August 2017

Robin Leach

1

1 reference

6 August 2017

Brad Pollock

2

1 reference

6 August 2017

Joseph Basler

3

1 reference

6 August 2017

Dean Troyer

4

1 reference

6 August 2017

Susan Naylor

5

1 reference

6 August 2017

Ian M Thompson

6

1 reference

6 August 2017

language of work or name

1 reference

1 May 2003

1 reference

Urologic Clinics of North America

6 August 2017

1 reference

6 August 2017

30

1 reference

6 August 2017

2

1 reference

6 August 2017

227-237

1 reference

6 August 2017

Cancer statistics, 2001

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Follow-up prostate cancer treatments after radical prostatectomy: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Low levels of prostate-specific antigen predict long-term risk of prostate cancer: results from the Baltimore Longitudinal Study of Aging

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Family history facilitates the early diagnosis of prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Family history and prostate cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2).

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Genetic variation of 3 beta-hydroxysteroid dehydrogenase type II in three racial/ethnic groups: implications for prostate cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Prostate cancer risk: associations with ultraviolet radiation, tyrosinase and melanocortin-1 receptor genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Reduced expression of hMSH2 and hMLH1 and risk of prostate cancer: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Recent trends in protein biochip technology

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

The IGF axis in the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Sex hormone-induced prostatic carcinogenesis in the noble rat: the role of insulin-like growth factor-I (IGF-I) and vascular endothelial growth factor (VEGF) in the development of prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

The epidemiology of prostatic cancer. Geographical distribution and time-trends

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Serum vitamin E and risk of cancer among Finnish men during a 10-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Prediagnostic serum levels of carotenoids and vitamin E as related to subsequent cancer in Washington County, Maryland

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Dietary carotenes, vitamin C, and vitamin E as protective antioxidants in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Critical assessment of the epidemiological data concerning the impact of antioxidant nutrients on cancer and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Prostate Cancer and Supplementation With α-Tocopherol and β-Carotene: Incidence and Mortality in a Controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Selenium in global food systems

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Vitamin E: beyond antioxidant function

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Vitamin E inhibits protein kinase c activity

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Brief report: the molecular basis of steroid 5 alpha-reductase deficiency in a large Dominican kindred

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

CIRRHOSIS AND CARCINOMA OF THE PROSTATE GLAND

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Piroxicam and other cyclooxygenase inhibitors: Potential for cancer chemoprevention

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Prostaglandins, their inhibitors and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Piroxicam inhibits the growth of an adenocarcinoma isograft in Fischer rats

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Sulindac for polyposis of the colon

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Induction of cyclo-oxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Induction of prostaglandin G/H synthase-2 in a canine model of spontaneous prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

Non-steroidal anti-inflammatory drugs and prostate cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

A population-based study of daily nonsteroidal anti-inflammatory drug use and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900178-7

7 January 2021

10.1016/S0094-0143(02)00178-7

Identifiers

DOI

1 reference

6 August 2017

1 reference